ArticleMolecular medicine reports2018

Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells.

Seung Taek Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.